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ABSTRACT 
This study aimed to evaluate the antidiarrheal effect of the aqueous extract of the leaves of C odorata (400 and 800 mg/kg). The antidiarrheal 
effect was evaluated on the diarrhoea induced by the castor oil, the charcoal test (intestinal transit time) and on the accumulation of the 
intestinal fluid induced by the castor oil (Enteropooling).The results obtained show that the aqueous extract at the doses used significantly 
decrease (p<0,001) the frequency of emission, the quantity and the onset of appearance of the faces induced by the castor oil. The aqueous 
extract of C odorata (400 and 800 mg/kg) does not decrease significantly the intestinal transit (p>0.05) but on the other hand significantly 
decrease (p<0.01) the accumulation of the fluid in the intestine induced by the castor oil. In conclusion the aqueous extract of C odorata (400 and 
800 mg/kg) has an antidiarrheal effect who could be explained by interference with the mechanisms of secretion of the electrolytes. These 
results would justify the use of plant on the traditional treatment of the diarrhoea. 
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INTRODUCTION 
In developing countries, people in rural areas often resort to 
traditional medicine to treat their diseases, including 
problems related to diarrhea. Indeed, diarrhea is a major 
cause of mortality and infant morbidity. Diarrheal diseases 
cause an estimated 1.8 million deaths each year in the world, 
of which 90 % are children under five years, most of whom 
live in developing countries 1. 17 % of children admitted to 
pediatrics die of diarrhea. They are the third leading cause of 
death for infectious diseases of all ages 2, 3 and the fifth 
leading cause of premature death in the worldwide 4. During 
the last 15 years, research has been undertaken to discover 
new drugs. It is becoming increasingly clear that plants can 
be a source of cheaper new products, especially for 
developing populations, and effective against diarrhea 5. For 
example, WHO in the Africa region encourages African 
countries to undertake research on medicinal plants and to 
promote their use in health care systems 6. C. odorata 
(Asteraceae) one of the medicinal plants much used in the 
American traditional herbal, Asian and African for the 
treatment of several pathologies. In Congo, it is used as a 
disinfectant and healing wounds 7. A leaf decoction is used to 
treat colds, flu, asthma, fever 8, skin infections, conjunctivitis 
9, 10, diabetes and malaria 11, diarrhea 12. The phytochemical 
study of the aqueous extract revealed the presence of 
saponins, alkaloids, glycosides-cardiotonics, steroids, tannins 
and flavonoids 13. Previous pharmacological work on this 
plant shows that it has several pharmacological properties 
such as: analgesic and anti-inflammatory 14, antibacterial 15, 
16, antioxidant 17 and antiulcer 18. This study aims to evaluate 
the antidiarrheal effect of the aqueous extract of leaves of C. 
odorata. 
MATERIAL AND METHOD 
Plant material 
The leaves of C. odorata collected in Brazzaville were used. 
Botanical identification of the plant material was done by 
Mousamboté, botanist systematist of Higher Normal School 
of Agronomy and Forestry (HNSAF) and confirmed at the 
botanical laboratory of Research Institute in Exact and 
Natural Sciences (RIENS) of Brazzaville where the samples of 
C.  odorata was compared with the reference samples of the  
herbarium at No. 1183, July 1965.  Plant material were dried 
and pulverized with a mortar. The aqueous extract of leaves 
of C. odorata was prepared by decoction. 250 g of powder of 
dry C. odorata leaves were mixed in 2500 ml of distilled 
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water. The mixture was boiled for 15 minutes. After cooling 
and filtration, the filtrate obtained was concentrated on a 
double boiler (60 °C). The concentrate obtained was 
preserved to evaluate the antidiarrheal effect. 
Animal material 
Albino rats (200 to 250 g) and albino mice (20 to 30 g) of 
either sex obtained from the Faculty of Science and 
Technology of Marien NGOUABI-University were used. They 
were fed with a standard feed and water ad libitum. They 
were acclimatized during one week before experimentation 
and were housed under standard conditions (12 h light and 
12 h dark) and at the temperature of 27 ± 1°C. The rules of 
ethics published by the International Association for the 
Study of Pain 19 have been considered. 
Castor oil induced diarrhoea in rat 
The method reported by Elion Itou, (2018b) 20 was used. The 
animals were divided into groups of 5 rats each. The 
different doses of the aqueous extract of leaves of C.odorata 
(400 and 800), loperamide (reference molecule, 10 mg / kg) 
and physiological saline (control, 0.5 ml/ 100g) were 
administered orally to groups, one hour prior castor oil 
administration (2 ml/rat). After castor oil administration, the 
animals were placed in metabolism cages to evaluate the 
frequency, the quantity of the faeces emitted as well as the 
onset of appearance of the diarrheal faeces (soft or liquids). 
The frequency and the faeces quantity were noted at 2, 4 and 
6 hours after administration of castor oil. 
Intestinal transit 
Intestinal transit was determined by the charcoal method 20. 
The various doses of the aqueous extract of leaves of 
C.odorata (400 and 800), loperamide (reference molecule, 10 
mg / kg), physiological saline (control, 0.5 ml / 100g) were 
administered orally to groups, one hour prior of 10% 
charcoal (10 ml / kg). 30 minutes after administration of the 
charcoal, the animals were sacrificed by cervical dislocation, 
the abdomen opened, the small intestine removed and 
placed on blotting paper. The small intestine is inspected, the 
distance traveled by the charcoal was measured using a scale 
and expressed as a percentage of the intestinal transit 
according to the formula: % T = d / D × 100; distance 
traveled by charcoal;  
D = total length of the small intestine. 
Enteropooling 
This study involves assessing the net quantity of fluid 
accumulated in the small intestine. The various doses of the 
aqueous extract of leaves of C.odorata (400 and 800), 
loperamide (reference molecule, 10 mg/kg) and distilled 
water (control, 0.5 ml/100g) were administered orally to 
groups, one hour prior administration of castor oil (2 ml/rat) 
21. 2 hours after castor oil, the rats were sacrificed by 
cervical dislocation. The small intestine was removed and 
weighed (P1). Subsequently it was emptied of its contents 
then and weighed again (P2) and its length (L) measured. 
The difference between the weights divided by the length 
gives the net quantity (Q) of the fluid accumulated: 
L
PP
Q
21
  
The intestinal contents of each group were collected in a 
tube and sent to the laboratory to determine the 
concentrations of Na + (sodium), K + (potassium) ions using 
a flame photometer ( Micro Touch Biochemistry Analyser). 
Statistical Analyze 
All values were expressed as mean ± ESM. Analysis of 
variance followed by Student-Fischer t test “t” was 
performed. The significance level was set at p<0.05 
RESULTS 
Effect on diarrhea induced by castor oil 
The administration of castor oil caused the stools to be shed. 
The results obtained show that loperamide and the aqueous 
extract at the doses used significantly reduce (p <0.001) the 
emission frequency as well as the quantity of faeces excreted 
(Table 1 and 2) during the 6 hours of observations compared 
to the control group. However, maximum decreases are 
observed the first two hours when loperamide and the 
aqueous extract at the dose of 800 mg/kg cause almost 
constipation of the animals. In contrast, loperamide and the 
aqueous extract at the doses used significantly reduce (p 
<0.001) the onset of the first diarrheal faeces apparition 
compared to the control group (Table 3). The onset of the 
first diarrheal faeces is 65.80 ± 1.01; 259.44 ± 1.44; 170.12 ± 
0.79 and 224.04 ± 1.02 min respectively for physiological 
saline, loperamide and aqueous extract at doses of 400 and 
800 mg/kg. 
 
Table 1: Effect of aqueous extract of C. odorata on the frequency of fecal excretion 
 Treatment 
 
Doses Frequency of faeces 
2H                           4H                          6H 
Control group 
loperamide 
C. odorata 
 
 0.5 mL/100 g 
 10 mg/kg 
400 mg/kg  
 800 mg/kg 
14.4±1.07 
00±00*** 
0,54±0,04*** 
00±00*** 
18.6±0.6 
1.16±0.21*** 
5.6±0.22*** 
3.37±0.11*** 
20.6±0.67 
2.26±0.18*** 
7.82±0.09*** 
4.48±0.18*** 
Each value represents the mean ± ESM; ***p<0.001 (Student t-test), versus control 
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Table 2: Effect of aqueous extract of C. odorata on faeces amount 
Treatment 
  
  Doses  Amount of faeces(g) Inhibition (%) 
2H 4H 6H 2H 4H 6H 
Control group  0.5 mL/100 g 6.72±0.18 8.84±0.24 10.16±0.09 /  / / 
  loperamide  10 mg/kg 00±00*** 0.63±0.07*** 1,63±0.40*** 100 92.87 83.95 
C. odorata 
 
400 mg/kg  0,21±0,18*** 3.84±0.60*** 4.52±0.07*** 96.75 56.56 55.51 
 800 mg/kg 00±00*** 1.57±0.13*** 2.68±0.03*** 100 82.23 74.11 
Each value represents the mean ± ESM; ***p<0.001 (Student t-test), versus control group 
 
Table 3: Effect of aqueous extract of C. odorata on the onset of fecal excretion 
Treatment Doses Onset (Min) 
Control group 0.5 mL/100 g 65.80±1.01 
Loperamide 10 mg/kg 259.44±1.44*** 
C. odorata 400 mg/kg 170.12±0.79*** 
800 mg/kg 224.04±1.02*** 
Each value represents the mean ± ESM; ***p<0.001 (Student t-test), versus control group 
 
Effect on intestinal Transit 
The results of the effect of the aqueous extract of the leaves 
of C.odorata on intestinal transit are shown in figure 1. They 
show that loperamide significantly reduces (p <0.001) 
intestinal transit compared to the control group 
(physiological water). However, the aqueous extract of   at 
the doses used did not significantly decrease intestinal 
transit (p> 0.05) compared with the control group. The 
intestinal transit values are 88.95 for control group; 31.35 
for loperamide (reference molecule); 85.59 and 77.59 for the 
aqueous extract at the respective doses of 400 and 800 mg / 
kg.
 
 
Figure 1: Effect of aqueous extract of C. odorata on intestinal transit. ***p<0.001 (Student t-test), versus control group; ns= no 
significant (p>0.05) test versus control group. 
 
Table 4:  Effect of the aqueous extract of C. odorata on intestinal excretion of N+ and K+ in mice 
Treatment Doses  Na+ (mmol) K+ (mmol) Ratio (N+/K+) 
Control group 0.5 mL/100 g 192.69 20.58 9.36 
Loperamide 10 mg/kg 89.001  21.53 4.13 
C. odorata 400 mg/kg 764.69 9.65 79.24 
800 mg/kg 758.04 18.43 41.13 
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Effect on intestinal fluid accumulation (Enteropooling) 
The results of the effect of the aqueous extract of C.odorata 
leaves on intestinal fluid accumulation are shown in figure. 2. 
They show that loperamide and the aqueous extract (800 mg 
/ kg) decrease significantly (p <0.01) fluid accumulation in 
the intestine compared to the control group. However, no 
significant decrease (p> 0.05) was observed with the 
aqueous extract at 400 mg/kg. The masses of the fluid 
collected are 10.17 for control group; of 4.18 for loperamide, 
10.02 for the 400 mg/kg of aqueous extract and 4.81 mg for 
the 800 mg/kg of aqueous extract. Moreover, the control, 
loperamide and the aqueous extract at the doses used (400 
and 800 mg / kg) eliminate more Na + ions than K + ions 
(ratio >1). 
 
 
Figure 2: Effect of the aqueous extract of C. odorata on intestinal fluid accumulation ***p<0.001 (Student t-test), versus control 
group; ns= no significant (p>0.05) test versus control group 
 
DISCUSSION 
Oral administration of castor oil caused diarrhea in rats. This 
has resulted in an increase in the frequency of emission and 
the amount of faeces excreted which are two important 
parameters in the definition of diarrhea. In fact castor oil 
contains ricinoleic acid which induces irritation and 
inflammation of the intestinal mucosa, leading to the release 
of prostaglandins which, in turn, modify the mucous fluid 
and the transport of electrolytes, thus preventing the 
reabsorption of  NaCl and water leading to a hypersecretory 
response and diarrhea 22. In fact, ricinoleic acid stimulates 
peristatic activity in the small intestine and modifies the 
permeability of electrolytes (Na, K) by inhibiting the 
intestinal activity Na/K ATPase). Inhibition of intestinal 
activity Na/K ATPase, reduces normal fluid absorption by 
activation of adenylate cyclase 23. In this study, the aqueous 
extract of C. odorata (400 and 800 mg/kg) significantly 
reduced the faeces frequency emission; the amount of faeces 
excreted and delayed the onset of diarrhea induced by castor 
oil such as loperamide (reference molecule). Indeed, 
loperamide is one of the most widely used and best known 
antidiarrheal because of the absence of central effects in 
adults and its preferential binding to the μ and δ receptors of 
intestinal tissue. It antagonizes castor oil-induced diarrhea 
and its action is due to its antisecretory and anti-motility 
properties 24. Loperamide reduces intestinal motility by 
direct effect on the circular and longitudinal muscles of the 
intestinal wall. The fact that the extract is resistant to castor 
oil-induced diarrhea suggests that the aqueous extract at the 
doses used (400 and 800 mg / kg) would act as the 
loperamide used as the reference molecule. In addition, the 
reduction of motility and gastrointestinal secretions is one of 
the mechanisms by which many antidiarrheal agents act 25. 
Therefore, in this study, the effect of the aqueous extract was 
evaluated on the intestinal transit as well as on the 
accumulation of intestinal fluid induced by castor oil. The 
results obtained show that the aqueous extract of leaves of C. 
odorata does not significantly decrease (p> 0.05) the 
intestinal transit in contrast to loperamide (p <0.001) 
compared to the control group. This result suggests that the 
antidiarrheal effect observed would not pass an acceleration 
of intestinal transit. In addition, studies conducted on 
enteropooling (accumulation of intestinal fluid) revealed 
that the aqueous extract of C. odorata significantly inhibits 
the accumulation of intestinal fluid (enteropooling) induced 
by castor oil with a reduction in weight and the volume of 
intestinal contents. From these results observed with the 
aqueous extract, it can be said that the reduction of the 
intestinal fluid accumulation would be due to a stimulation 
of the absorption of electrolytes of the intestinal lumen 
comparable to the inhibition of hypersecretion. According to 
different physiopathological conditions of diarrhea, 
hypermotility characterizes diarrhea where the secretory 
component is not the responsible factor. It is possible that 
the extract may reduce diarrhea by increasing the 
reabsorption of electrolytes and water or by inhibiting the 
induction of intestinal fluid accumulation. However, it is 
known that prostaglandins stimulate gastrointestinal 
motility and secretion of water and electrolytes. The 
mechanism related to this would be associated with the dual 
effects of intestinal motility on both the transport of water 
and electrolytes (decreased absorption of Na + and K +) than 
on the intestinal mucosa 21, 26, 27. In this study, it was 
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demonstrated that the aqueous extract of C.odorata at the 
doses used excrete more Na + than K + compared to the 
control and loperamide, which seems to confirm our 
hypothesis on the probable mechanism of the observed 
antidiarrheal effect. Other authors have already 
demonstrated the antidiarrheal effect of plant extracts 20. 
Indeed, these authors demonstrated the antidiarrheal effect 
of the aqueous extract (400 and 800 mg/kg) of the stem bark 
of Ceiba pentandra. The phytochemical study carried out 
previously had shown the presence of saponins, alkaloids, 
flavonoids, cardiotonic-heterosids, steroids and terpenoïds 
as well as tannins 13. It was reported by various researchers 
that tannins, saponins and flavonoids can be responsible for 
antidiarrheal actions 28. 
CONCLUSION 
The objective of this work was to evaluate the antidiarrheal 
effect of the aqueous leaf extract of C. odorata. It appears 
from this study that the aqueous extract of C. odorata has an 
antidiarrheal effect. This effect could be achieved by 
reducing intestinal secretions and not by increasing 
intestinal transit. These results could explain the traditional 
use of C. odorata in the treatment of diarrhea. 
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